We are live on ! Find out more
DY

Dowling & Yahnke Portfolio holdings

AUM $2.15B
1-Year Est. Return 10.82%
This Fund
S&P 500
This Quarter Est. Return
+6.7%
1 Year Est. Return
-10.82%
3 Year Est. Return
+34.82%
5 Year Est. Return
+71.23%
10 Year Est. Return
–
AUM
$1.46B
AUM Growth
+$60.5M
Cap. Flow
-$15M
Cap. Flow %
-1.03%
Top 10 Hldgs %
24.4%
Holding
345
New
17
Increased
119
Reduced
154
Closed
8

Top Buys

Rank Stock Value
1
VOO icon
Vanguard S&P 500 ETF
VOO
+$3.65M
2
VWOB icon
Vanguard Emerging Markets Government Bond ETF
VWOB
+$1.5M
3
UBER icon
Uber
UBER
+$956K
4
ARKK icon
ARK Innovation ETF
ARKK
+$920K
5
EMB icon
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
+$895K

Top Sells

Rank Stock Value
1
IONS icon
Ionis Pharmaceuticals
IONS
+$9.61M
2
IWC icon
iShares Micro-Cap ETF
IWC
+$2.84M
3
RS icon
Reliance Steel & Aluminium
RS
+$2.52M
4
MZTI
The Marzetti Company
MZTI
+$1.77M
5
CACI icon
CACI
CACI
+$1.42M

Sector Composition

Rank Sector Weight
1 Miscellaneous 24.77%
2 Technology 16.8%
3 Financials 11.51%
4 Healthcare 11.33%
5 Consumer Staples 8.87%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GPX
326
DELISTED
GP Strategies Corp.
GPX
$204K 0.01%
11,685
+1,515
+15% +$21.2K
CTVA icon
327
Corteva
CTVA
$56B
$200K 0.01%
+4,300
New +$190K
ARCC icon
328
Ares Capital
ARCC
$14.3B
$199K 0.01%
10,620
-1,417
-12% -$25.5K
VACQU
329
DELISTED
Vector Acquisition Corporation Unit
VACQU
$190K 0.01%
+15,000
New +$177K
GRFS
330
Grifois
GRFS
$5.23B
$189K 0.01%
10,955
– –
PBR icon
331
Petrobras
PBR
$119B
$187K 0.01%
22,000
– –
IEZ icon
332
iShares US Oil Equipment & Services ETF
IEZ
$386M
$134K 0.01%
10,000
– –
BCRX icon
333
BioCryst Pharmaceuticals
BCRX
$2.51B
$112K 0.01%
11,000
-5,000
-31% -$51.6K
FBIO icon
334
Fortress Biotech
FBIO
$92.4M
$71K ﹤0.01%
1,333
– –
GERN icon
335
Geron
GERN
$970M
$62K ﹤0.01%
39,047
– –
ADMS
336
DELISTED
Adamas Pharmaceuticals
ADMS
$62K ﹤0.01%
13,000
– –
RGLS
337
DELISTED
Regulus Therapeutics
RGLS
$19K ﹤0.01%
1,200
– –
BIO icon
338
Bio-Rad Laboratories Class A
BIO
$10.4B
– –
-681
Closed -$397K
BX icon
339
Blackstone
BX
$107B
– –
-4,638
Closed -$301K
JMST icon
340
JPMorgan Ultra-Short Municipal Income ETF
JMST
$7.26B
– –
-10,480
Closed -$535K
LUMN icon
341
Lumen
LUMN
$6.23B
– –
-35,139
Closed -$343K
NVS icon
342
Novartis
NVS
$292B
– –
-2,602
Closed -$246K
JHB
343
DELISTED
Nuveen Corporate Income November 2021 Target Term Fund
JHB
– –
-15,500
Closed -$143K
PANA.WS
344
DELISTED
Panacea Acquisition Corp. Redeemable warrants, each whole warrant exercisable for one share of Class
PANA.WS
– –
-11,063
Closed -$35K
BMY.RT
345
DELISTED
Bristol-Myers Squibb Company Contingent Value Rights
BMY.RT
– –
-20,239
Closed -$14K
10 11 12 13
14

Similar funds

AC
Alleghany Corporation New York $2.21B AUM 10.5% 1-Year Est. Return
CCM
Covington Capital Management Los Angeles, California $2.32B AUM 12.18% 1-Year Est. Return
MIAN
Mariner Independent Advisor Network Overland Park, Kansas $2.33B AUM 14.85% 1-Year Est. Return
APA
American Portfolios Advisors Holbrook, New York $2.36B AUM 14.59% 1-Year Est. Return
IC
Inverness Counsel New York $1.8B AUM 9.9% 1-Year Est. Return
SCA
Salient Capital Advisors Houston, Texas $1.74B AUM 12.95% 1-Year Est. Return
ACM
AlphaCrest Capital Management New York $1.64B AUM 23.4% 1-Year Est. Return
W
Wealthsimple Toronto, Ontario, Canada $2.69B AUM 18.39% 1-Year Est. Return

Dowling & Yahnke's Q1 2021 Portfolio in Review

As of Q1 2021, Dowling & Yahnke held 345 positions worth $1.46B, up 4.3% from $1.4B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Dowling & Yahnke's Q1 2021 filing shows 17 new, 119 increased, 154 reduced and 8 closed positions. Its largest new stake was Uber: 17,129 shares worth $934K. The largest sale was Ionis Pharmaceuticals, an estimated $9.61M.

By sector, the portfolio is most concentrated in Miscellaneous at 25% of assets, up from 24% a quarter earlier, followed by Technology and Financials.

  • Dowling & Yahnke's largest Q1 2021 buy was Uber: 17,129 shares worth $934K.
  • Dowling & Yahnke added most to Vanguard S&P 500 ETF in Q1 2021, an estimated $3.65M increase.
  • Dowling & Yahnke's biggest Q1 2021 reduction was Ionis Pharmaceuticals, cutting an estimated $9.61M.
  • Dowling & Yahnke fully exited JPMorgan Ultra-Short Municipal Income ETF in Q1 2021, selling an estimated $535K.
  • Dowling & Yahnke's ten largest holdings make up 24% of its $1.46B portfolio in Q1 2021.
  • Dowling & Yahnke opened 17 new positions and closed 8 in Q1 2021.
  • Dowling & Yahnke's portfolio value rose 4.3% quarter-over-quarter to $1.46B.

Based on Dowling & Yahnke's 13F filing for Q1 2021, filed 29 Apr 2021.